RFK Jr. says annual COVID-19 shots no longer advised for healthy children, pregnant women - public health expert explains new guidance
Indiana: On May 27, 2025, Health and Human Services Secretary Robert F.
Kennedy
Jr. announced that the Centers for Disease Control and Prevention will no longer include the COVID-19 vaccine on the list of immunizations it recommends for healthy children and pregnant women.
The announcement, made in a video posted on the social platform X, comes on the heels of another announcement, made on May 20, in which the Food and Drug Administration revealed that it will approve new versions of the vaccine only for adults 65 years of age and older and for people with one or more risk factors for severe COVID-19 outcomes.
The agency will require vaccine manufacturers to conduct clinical trials to demonstrate that the vaccine benefits low-risk groups.
The Conversation US asked
Libby Richards
, a nursing professor from Purdue University involved in public health promotion, to explain what these announcements mean for the general public.
Why are HHS and
FDA
diverging from past practice?
Currently, getting a yearly COVID-19 vaccine is recommended for everyone ages 6 months and older, regardless of their health risk.
In the video announcing the plan to remove the vaccine from the CDC's recommended immunization schedule for healthy children and healthy pregnant women, Kennedy spoke alongside
National Institutes of Health
Director
Jay Bhattacharya
and FDA Commissioner
Marty Makary
.
The trio cited a lack of evidence to support vaccinating healthy children. They did not explain the reason for the change to the vaccine schedule for pregnant people, who have previously been considered at high-risk for severe COVID-19.
Similarly, in the FDA announcement made a week prior, Makary and the agency's head of vaccines,
Vinay Prasad
, said that public health trends now support limiting vaccines to people at high risk of serious illness instead of a universal COVID-19 vaccination strategy.
Was this a controversial decision or a clear consensus?
Many public health experts and professional health care associations have raised concerns about Kennedy's latest announcement, saying it contradicts studies showing that COVID-19 vaccination benefits pregnant people and children.
The American College of Obstetrics and Gynecology, considered the premier professional organisation for that medical specialty, reinforced the importance of COVID-19 vaccination during pregnancy, especially to protect infants after birth.
Likewise, the American Academy of Pediatrics pointed to the data on hospitalisations of children with COVID-19 during the 2024-to-2025 respiratory virus season as evidence for the importance of vaccination.
Kennedy's announcement on children and pregnant women comes roughly a month ahead of a planned meeting of the Advisory Committee on Immunization Practices, a panel of vaccine experts that offers guidance to the CDC on vaccine policy.
The meeting was set to review guidance for the 2025-to-2026 COVID-19 vaccines. It's not typical for the CDC to alter its recommendations without input from the committee.
FDA officials Makary and Prasad also strayed from past established vaccine regulatory processes in announcing the FDA's new stance on recommendations for healthy people under age 65.
Usually, the FDA broadly approves a vaccine based on whether it is safe and effective, and decisions on who should be eligible to receive it are left to the CDC, which bases its decision on the advisory committee's research-based guidance.
The advisory committee was expected to recommend a risk-based approach for the COVID-19 vaccine, but it was also expected to recommend allowing low-risk people to get annual COVID-19 vaccines if they want to. The CDC's and FDA's new policies on the vaccine will likely make it difficult for healthy people to get the vaccine.
What conditions count as risk factors?
The CDC lists several medical conditions and other factors that increase peoples' risk for severe COVID-19. These conditions include cancer, diabetes, heart disease, obesity, chronic kidney disease and some lung conditions like COPD and asthma. Pregnancy is also on the list.
The article authored by Makary and Prasad describing the FDA's new stance on the vaccine also contain a lengthy list of risk factors and notes that about 100 million to 200 million people will fall into this category and will thus be eligible to get the vaccine. Pregnancy is included. Reversing the recommendation for vaccinating healthy pregnant women thus contradicts the new framework described by the FDA.
Studies have documented that COVID-19 vaccines are safe during pregnancy and may reduce the risk of stillbirth. A study published in May 2025 using data from 26,783 pregnancies found a link between COVID-19 infection before and during pregnancy and an increased risk for spontaneous abortions.
Importantly, a 2024 analysis of 120 studies including a total of 168,444 pregnant women with COVID-19 infections did not find enough evidence to suggest the infections are a direct cause of early pregnancy loss.
Nonetheless, the authors did state that COVID-19 vaccination remains a crucial preventive measure for pregnant women to reduce the overall risk of serious complications in pregnancy due to infection.
Immune changes during pregnancy increase the risk of severe illness from respiratory viruses. Vaccination during pregnancy also provides protection to the fetus that lasts into the first few months of life and is associated with a lower risk of COVID-19 related hospitalisation among infants.
The changes to the CDC's and the FDA's plan for COVID-19 vaccines also leave out an important group - caregivers and household members of people at high risk of severe illness from infection. This omission leaves high-risk people more vulnerable to exposure to COVID-19 from healthy people they regularly interact with. Multiple countries with risk-based vaccination policies do include this group.
What about vaccines for children?
High-risk children age 6 months and older who have conditions that increase the risk of severe COVID-19 are still eligible for the vaccine. Existing vaccines already on the market will remain available, but it is unclear how long they will stay authorised and how the change in vaccine policy will affect childhood vaccination overall.
To date, millions of children have safely received the COVID-19 vaccine. Data on whether children benefit from annual COVD-19 vaccines is less clear. Parents and clinicians make vaccination decisions by weighing potential risks with potential benefits.
Will low-risk people be able to get a COVID-19 shot?
Not automatically. Kennedy's announcement does not broadly address healthy adults, but under the new FDA framework, healthy adults who wish to receive the fall COVID-19 vaccine will likely face obstacles.
Health care providers can administer vaccines "off-label", but insurance coverage is widely based on FDA recommendations. The new, narrower FDA approval will likely reduce both access to COVID-19 vaccines for the general public and insurance coverage for COVID-19 vaccines.
Under the Affordable Care Act,
Medicare
, Medicaid and private insurance providers are required to fully cover the cost of any vaccine endorsed by the CDC. Kennedy's announcement will likely limit insurance coverage for COVID-19 vaccination.
Overall, the move to focus on individual risks and benefits may overlook broader public health benefits. Communities with higher vaccination rates have fewer opportunities to spread the virus. (The Conversation) GRS GRS
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
34 minutes ago
- Hindustan Times
COVID spiking again: Top 6 nutrients you need to include in your diet for better immunity
As COVID-19 cases are rising again, it is important to prioritise your diet, as a nutritionally strong diet can strengthen your immunity and help your body fight infections more effectively. While precautions remain essential and nutrition alone can't combat the virus, having strong immunity supported by a rich, healthy diet is an advantage you will need this season. Garima Dev Verman, Dietitian and Health Educator at The Healthy Indian Project (THIP) shared with HT Lifestyle a guide, covering the key nutrients one should add to the diet. Along with that, the guide also outlines some of the common health myths: Gargling with warm water and salt, apple cider vinegar, or lemon can eliminate coronavirus from your While these may soothe your throat, they cannot kill or remove the virus once it has infected your respiratory system. Taking mega doses of supplements such as zinc,Vitamin C and drinking green tea or cow urine, have been shown to stop a COVID-19 None of these supplements have been proven to prevent or cure COVID-19. Relying on unproven remedies can be really life threatening or dangerous and delay the needed proper treatment. The coronavirus is foodborne and transmitted through the consumption of COVID-19 is primarily a respiratory virus transmitted from person to person through tiny drops of saliva or mucus that come out of the mouth or nose when someone coughs, sneezes, talks, or breathes. . There is no evidence it spreads via cooked meat or other food items. Eating alkaline foods or alkaline water with a pH above 8.5 can neutralise the The body tightly regulates blood pH, and diet cannot change this. Alkaline foods do not neutralise or kill the virus. Eating a plant-based diet rich in fruits, vegetables, herbs, whole grains, legumes, nuts, and seeds can provide immunity against COVID-19. Fact: While a healthy, homemade, balanced diet supports overall immune function, it is effective only when maintained consistently over time. Starting to eat nutritious foods during the pandemic will not instantly build immunity against COVID-19. Immunity develops gradually and depends on multiple factors. No diet can prevent or cure COVID-19. Adding to this, Sudipta Sengupta, Founder & CEO of The Healthy Indian Project (THIP), further unpacked how debunking myths is the need of the hour. He said, 'As COVID cases rise again in parts of India, we must remember that fighting the virus is not just a medical battle but also a battle against misinformation. During the last pandemic, the infodemic caused real harm. Despite growing awareness, low health literacy and a complex health information ecosystem still leave people vulnerable. It's critical for social media platforms and fact-checkers to stay vigilant.' ALSO READ: Doctor shares top nutrients you need to include in your diet for good kidney health Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
News18
an hour ago
- News18
UP Students Build Portable Ventilator For Just Rs 15,000, Call It 'Lesson From Covid-19'
Last Updated: One of the developers said the project was born out of the Covid-19 pandemic when the scarcity of ventilators and oxygen cylinders turned hospitals into battlegrounds In a remarkable display of ingenuity and social commitment, four final-year engineering students from the Kamla Nehru Institute of Technology (KNIT) in Sultanpur, Uttar Pradesh, have developed a portable, battery-powered ventilator that could revolutionise emergency care in underserved regions of the country. At a time when the price of medical devices continues to soar beyond the reach of the average household, this team of Electrical Engineering students – Yash Mishra, Siddhant Mohan Ojha, Vaibhav Yadav, and Aditya Rauniyar – has created a low-cost, lightweight ventilator aimed at delivering immediate oxygen support to patients with respiratory distress. The compact ventilator is specifically designed to be used in emergency situations, especially in places where medical infrastructure is either minimal or non-existent. The prototype, assembled for just Rs 15,000, can monitor oxygen saturation and air pressure in real time using components like the Arduino Uno microcontroller, a SpO₂ sensor, and air pressure sensors. Speaking to Local18, Vaibhav Yadav, one of the developers, said the project was born out of the harrowing memories of the Covid-19 pandemic, when the scarcity of ventilators and oxygen cylinders turned hospitals into battlegrounds. 'We wanted to build something accessible, affordable, and effective; a device that could be used even in rural areas or during patient transport," Yadav explained. The team received crucial technical guidance from their project mentor Er Dilip Kumar Patel and Head of Department Dr Saurabh Mani Tripathi, who lauded the innovation as a potential game-changer in rural and mobile healthcare delivery. Dr Tripathi emphasised that the ventilator's portability and battery-operated design make it highly suitable for ambulances, village clinics, mobile medical units, and even home care. What sets this project apart is not only the cost – which could drop to Rs 8,000 with mass production – but also the depth of research behind it. The students referred to international research journals, including those published by the IEEE, to inform the device's functionality and safety mechanisms. The team is now hoping for support from government agencies or startups to take their innovation forward. 'India faces huge disparities in healthcare access," said Siddhant Ojha, adding that if their ventilator can be manufactured and distributed widely, it could save countless lives, especially in areas where help often comes too late. First Published: June 13, 2025, 18:38 IST
Time of India
2 hours ago
- Time of India
Zero-sugar soda cans recalled in the US: FDA cites class II health risk; know how serious it is
A major soda recall is underway following the discovery of thousands of cans of Dr. Pepper Zero Sugar containing regular, full-sugar soda. The mislabeling issue, which impacts multiple southeastern states, has triggered a voluntary recall. The U.S. Food and Drug Administration (FDA) confirmed the recall and has officially categorized it as a Class II health risk. The 'Class II health risk' means that the affected products may cause 'temporary or medically reversible adverse health consequences' if consumed. What's being recalled? According to the FDA, the recall involves 19,203 cases of Dr. Pepper Zero Sugar 12-ounce aluminum cans, sold in 12-pack and 24-pack formats. As per the report, the affected products were distributed to retail locations across Florida, Georgia, and South Carolina. The mislabeling means that while the cans are labeled as "Zero Sugar," they might actually contain full-sugar soda. This presents potential risks for individuals who have conditions such as diabetes, obesity, heart disease, or those simply trying to manage their sugar intake. However , the good news is that the recalled cans can be easily identified by the production code 'XXXXRS05165' and a best-by date of February 16, 2026, printed on the packaging. When did the issue come to light? The issue first came to light when the product's manufacturer, Keurig Dr Pepper, initiated a voluntary recall on May 23, 2025. The FDA then officially listed the incident as a Class II recall on June 5. Per the FDA classification system, a Class II recall occurs when 'use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.' In a statement to ABC News, Keurig Dr Pepper said the affected soda cans were produced at a PepsiCo bottling facility that is licensed to manufacture certain Keurig Dr Pepper products. The company added that 'the recalled product has been removed from stores' and did not report receiving any complaints or reports of illness related to the error. Typically, Dr. Pepper Zero Sugar is made using aspartame, a sugar substitute, to offer a low-calorie alternative to sugary sodas. Consuming large amounts of sugar when expecting a sugar-free product could be particularly risky for people with blood sugar sensitivities. The Centers for Disease Control and Prevention (CDC) warns that added sugars in beverages like sodas are a major contributor to health conditions such as type 2 diabetes, high blood pressure, and obesity. Source: Canva Consumers are advised not to consume the product if it matches the recalled batch. You can report any adverse reactions or quality issues to the FDA's MedWatch Safety Information and Adverse Event Reporting Program. How the FDA classifies recalls based on health hazards When a product is recalled, the U.S. Food and Drug Administration (FDA) assigns it a classification to indicate the level of health risk it poses to the public. These recall classifications—Class I, II, or III—are based on the potential severity of the health consequences associated with using or being exposed to the product. Class I Recall This is the most serious type of recall. It applies to situations where there is a reasonable probability that the use of or exposure to the product will result in serious health problems or even death. These recalls often involve issues like contamination, incorrect labeling on life-saving drugs, or malfunctioning medical devices. Class II Recall This classification is used when the product may cause temporary or medically reversible health effects, but the risk of serious injury is considered remote. These recalls may involve products with minor labeling errors or products that fail to meet quality standards but are not life-threatening. Class III Recall A Class III recall is issued when the product is unlikely to cause any adverse health effects. These are generally administrative in nature and may involve minor violations, such as packaging defects or slight deviations from labeling requirements, that do not pose a health hazard. One step to a healthier you—join Times Health+ Yoga and feel the change
